Research Scientist, Carver College of Medicine
How do you outsmart cancer? One way being explored by University of Iowa cancer researcher Kristina Thiel is to target it more accurately using personalized treatments. Thiel is a co-founder of Immortagen, a company that is enhancing personalized cancer treatment for each patient. Thiel and her team are developing an exhaustive genetic sequencing tool so doctors can determine which drugs would be the most effective based on genetic mutations in each individual patient’s tumor. Learn more.
Banner location: not on display—